1. Rethinking the Use of Routine Platelet Transfusions for Head Injured Patients on Antiplatelet Therapy
- Author
-
Robert Behm, Paul Granet, Gabriel O Ologun, Mojirola Alegbejo-Olarinoye, and Arpitha Pamula
- Subjects
business.industry ,Traumatic brain injury ,Head injury ,General Engineering ,Baseline risk ,030204 cardiovascular system & hematology ,medicine.disease ,Trauma ,humanities ,antiplatelet therapy ,Head trauma ,03 medical and health sciences ,0302 clinical medicine ,Platelet transfusion ,Anesthesia ,Emergency Medicine ,Internal Medicine ,head trauma ,Medicine ,Platelet ,business ,030217 neurology & neurosurgery ,head injury ,transfusion - Abstract
Traumatic brain injury is responsible for over one million hospital visits, and thousands of deaths annually. The aging population is associated with an increased use of anticoagulation and antiplatelet agents which complicates traumatic brain injury. The use of antiplatelet agents significantly increases baseline risk of intracranial hemorrhage. However, routine platelet transfusion in an attempt to reverse the effects of antiplatelet agents may be detrimental. Here, we report a case of an elderly woman with mild traumatic brain injury, who suffered a tragic demise after platelet transfusion.
- Published
- 2019